Protalix BioTherapeutics, Inc(NYSE MKT:PLX) 
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, rest of Latin America, and internationally. The company o...
Website: http://www.protalix.com
Founded: 1993
Full Time Employees: 196
CEO: Dror Bashan
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.52
H 2.57
L 2.36
C 2.38
V 842,449
10EMA 2.38
20EMA 2.38
60EMA 2.38
120EMA 2.38
250EMA 2.38